Autonomix Presents Promising PoC Study Data on Rapid Pain Relief in Pancreatic Cancer Patients Across All Disease Stages

Autonomix Medical presented new subgroup clinical data at the 2026 ASCO Gastrointestinal Symposium, showing rapid and durable pain relief in pancreatic cancer patients across all disease stages, including late-stage patients with limited treatment options. The analysis demonstrated consistent pain reduction regardless of disease severity, with significant pain reduction observed from Stage 2 through Stage 4. The findings reinforce Autonomix's belief that a targeted, nerve-based approach has the potential to provide meaningful relief in pancreatic cancer pain.